开云app官网登录入口网页版-官方正版

#持续病毒学应答#

15篇内容 | 952人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2215109, encodeId=fc96221510948, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=30872089e03' target=_blank style='color:#2F92EE;'>#丙型肝炎#</a> <a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=特别关注｜丙型肝炎持续病毒学应答后肝癌发生的危险因素及预测模型, objectType=article, longId=834265, objectId=81a88342650e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719493607463_8538692.png, objectUrl=/article/show_article.do?id=81a88342650e, replyNumber=0, likeNumber=89, createdTime=2024-07-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=81a88342650e, moduleTitle=特别关注｜丙型肝炎持续病毒学应答后肝癌发生的危险因素及预测模型, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=81a88342650e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2041521, encodeId=c10320415215e, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=Cancer：丙型肝炎病毒感染和肝细胞癌患者持续病毒学应答与临床预后的关系, objectType=article, longId=737348, objectId=abbae37348fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abbae37348fc, replyNumber=0, likeNumber=94, createdTime=2022-10-16, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abbae37348fc, moduleTitle=Cancer：丙型肝炎病毒感染和肝细胞癌患者持续病毒学应答与临床预后的关系, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=abbae37348fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041520, encodeId=2086204152045, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=J Hepatol：HCV肝硬化患者持续病毒学应答后肝脏和非肝脏相关结局的发生率, objectType=article, longId=218539, objectId=57a421853972, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57a421853972, replyNumber=0, likeNumber=0, createdTime=2022-08-09, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57a421853972, moduleTitle=J Hepatol：HCV肝硬化患者持续病毒学应答后肝脏和非肝脏相关结局的发生率, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=57a421853972)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041519, encodeId=6eec2041519bf, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=J Gastroenterology：直接作用抗病毒药持续病毒学应答对HCV肝硬化患者胃食管静脉曲张, objectType=article, longId=187606, objectId=e3cd18e60695, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3cd18e60695, replyNumber=0, likeNumber=67, createdTime=2020-07-16, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3cd18e60695, moduleTitle=J Gastroenterology：直接作用抗病毒药持续病毒学应答对HCV肝硬化患者胃食管静脉曲张, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e3cd18e60695)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041518, encodeId=6662204151833, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=Clin Gastroenterology H：持续病毒学应答对慢性丙型肝炎病毒感染患者的长期益处, objectType=article, longId=186632, objectId=f8e61866328b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8e61866328b, replyNumber=0, likeNumber=0, createdTime=2020-06-19, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8e61866328b, moduleTitle=Clin Gastroenterology H：持续病毒学应答对慢性丙型肝炎病毒感染患者的长期益处, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f8e61866328b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041516, encodeId=824e204151669, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=AP&T：对丙型肝炎治疗的持续病毒学应答降低了与2型糖尿病相关的并发症的发生率, objectType=article, longId=160234, objectId=2e3216023442, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e3216023442, replyNumber=0, likeNumber=129, createdTime=2019-12-02, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e3216023442, moduleTitle=AP&T：对丙型肝炎治疗的持续病毒学应答降低了与2型糖尿病相关的并发症的发生率, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=2e3216023442)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041517, encodeId=b4c8204151e1f, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=聚乙二醇干扰素λ治疗丁型肝炎24周后出现持续病毒学应答, objectType=article, longId=164170, objectId=e28a1641e0ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e28a1641e0ba, replyNumber=0, likeNumber=75, createdTime=2019-11-17, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e28a1641e0ba, moduleTitle=聚乙二醇干扰素λ治疗丁型肝炎24周后出现持续病毒学应答, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e28a1641e0ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041513, encodeId=641a204151351, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=Hepatology：持续病毒学应答对肝病患者的影响如何？, objectType=article, longId=128778, objectId=115f128e78a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=115f128e78a5, replyNumber=0, likeNumber=90, createdTime=2018-12-20, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=115f128e78a5, moduleTitle=Hepatology：持续病毒学应答对肝病患者的影响如何？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=115f128e78a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041515, encodeId=1d4d20415154d, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=J Viral Hepat：肝硬化、高龄、较高的BMI是获得可持续病毒学应答的晚期肝纤维化HCV患者的危险因素, objectType=article, longId=142592, objectId=cd51142592a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd51142592a7, replyNumber=0, likeNumber=122, createdTime=2019-01-17, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd51142592a7, moduleTitle=J Viral Hepat：肝硬化、高龄、较高的BMI是获得可持续病毒学应答的晚期肝纤维化HCV患者的危险因素, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=cd51142592a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041512, encodeId=049620415128b, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=Hepatol：晚期肝病患者接受直接抗病毒药物治疗获得持续病毒学应答后对死亡率的影响, objectType=article, longId=110601, objectId=5ce811060188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ce811060188, replyNumber=0, likeNumber=95, createdTime=2017-12-23, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ce811060188, moduleTitle=Hepatol：晚期肝病患者接受直接抗病毒药物治疗获得持续病毒学应答后对死亡率的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=5ce811060188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041514, encodeId=c9e22041514e5, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=J Viral Hepat肝硬化、高龄、较高的身体质量指数是获得持续病毒学应答的慢性丙型肝炎患者的危险因素, objectType=article, longId=135563, objectId=10cc1355633a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10cc1355633a, replyNumber=0, likeNumber=75, createdTime=2018-06-25, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10cc1355633a, moduleTitle=J Viral Hepat肝硬化、高龄、较高的身体质量指数是获得持续病毒学应答的慢性丙型肝炎患者的危险因素, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=10cc1355633a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041511, encodeId=fe6f204151121, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=J Hepatol：持续病毒学应答对肝癌风险的影响, objectType=article, longId=82159, objectId=e6798215914, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6798215914, replyNumber=0, likeNumber=80, createdTime=2017-06-22, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6798215914, moduleTitle=J Hepatol：持续病毒学应答对肝癌风险的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e6798215914)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041510, encodeId=f4c1204151039, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=NEJM：Ledipasvir/Sofosbuvir治疗提高了HIV-1/HCV共感染患者的持续病毒学应答率, objectType=article, longId=53683, objectId=f61b53683e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f61b53683e0, replyNumber=0, likeNumber=81, createdTime=2016-03-03, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f61b53683e0, moduleTitle=NEJM：Ledipasvir/Sofosbuvir治疗提高了HIV-1/HCV共感染患者的持续病毒学应答率, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f61b53683e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041509, encodeId=7ae6204150942, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=JAMA：持续病毒学应答与丙型肝炎, objectType=article, longId=18335, objectId=825318335ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=825318335ba, replyNumber=0, likeNumber=69, createdTime=2013-12-08, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=825318335ba, moduleTitle=JAMA：持续病毒学应答与丙型肝炎, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=825318335ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041508, encodeId=1d3520415082b, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=JAMA：持续病毒学应答或增慢性丙肝患者存活率, objectType=article, longId=14066, objectId=8e4b14066b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e4b14066b9, replyNumber=0, likeNumber=60, createdTime=2013-10-06, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e4b14066b9, moduleTitle=JAMA：持续病毒学应答或增慢性丙肝患者存活率, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=8e4b14066b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041507, encodeId=4dcb204150e85, content=<a href='/topic/show?id=88fe5634989' target=_blank style='color:#2F92EE;'>#持续病毒学应答#</a>, objectTitle=J Hepatol：胰岛素抵抗（IR）降低丙肝持续病毒学应答率, objectType=article, longId=3835, objectId=97e0383515, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97e0383515, replyNumber=0, likeNumber=56, createdTime=2012-06-07, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97e0383515, moduleTitle=J Hepatol：胰岛素抵抗（IR）降低丙肝持续病毒学应答率, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=97e0383515)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

持续病毒学应答

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肝癌# #丙型肝炎# #持续病毒学应答#

特别关注｜丙型肝炎持续病毒学应答后肝癌发生的危险因素及预测模型

2024-07-15发表于上海

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

Cancer：丙型肝炎病毒感染和肝细胞癌患者持续病毒学应答与临床预后的关系

2022-10-16

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

J Hepatol：HCV肝硬化患者持续病毒学应答后肝脏和非肝脏相关结局的发生率

2022-08-09

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

J Gastroenterology：直接作用抗病毒药持续病毒学应答对HCV肝硬化患者胃食管静脉曲张

2020-07-16

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

Clin Gastroenterology H：持续病毒学应答对慢性丙型肝炎病毒感染患者的长期益处

2020-06-19

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

AP&T：对丙型肝炎治疗的持续病毒学应答降低了与2型糖尿病相关的并发症的发生率

2019-12-02

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

聚乙二醇干扰素λ治疗丁型肝炎24周后出现持续病毒学应答

2019-11-17

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

Hepatology：持续病毒学应答对肝病患者的影响如何？

2018-12-20

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

J Viral Hepat：肝硬化、高龄、较高的BMI是获得可持续病毒学应答的晚期肝纤维化HCV患者的危险因素

2019-01-17

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

Hepatol：晚期肝病患者接受直接抗病毒药物治疗获得持续病毒学应答后对死亡率的影响

2017-12-23

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

J Viral Hepat肝硬化、高龄、较高的身体质量指数是获得持续病毒学应答的慢性丙型肝炎患者的危险因素

2018-06-25

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

J Hepatol：持续病毒学应答对肝癌风险的影响

2017-06-22

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

NEJM：Ledipasvir/Sofosbuvir治疗提高了HIV-1/HCV共感染患者的持续病毒学应答率

2016-03-03

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

JAMA：持续病毒学应答与丙型肝炎

2013-12-08

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

JAMA：持续病毒学应答或增慢性丙肝患者存活率

2013-10-06

heli0118 (审核中...)

前往app查看评论内容

#持续病毒学应答#

J Hepatol：胰岛素抵抗（IR）降低丙肝持续病毒学应答率

2012-06-07

科室
- - 订阅+
  - 更多科室
工具
服务